![]() |
Name |
(E)-3-[(6S,7S)-6-(2,4-dihydroxy-6-methylbenzoyl)oxy-7-hydroxy-7-methyl-8-oxo-5,6-dihydro-1H-isochromen-3-yl]prop-2-enoic acid
|
Molecular Formula | C21H20O9 | |
IUPAC Name* |
(E)-3-[(6S,7S)-6-(2,4-dihydroxy-6-methylbenzoyl)oxy-7-hydroxy-7-methyl-8-oxo-5,6-dihydro-1H-isochromen-3-yl]prop-2-enoic acid
|
|
SMILES |
CC1=CC(=CC(=C1C(=O)O[C@H]2CC3=C(COC(=C3)/C=C/C(=O)O)C(=O)[C@@]2(C)O)O)O
|
|
InChI |
InChI=1S/C21H20O9/c1-10-5-12(22)8-15(23)18(10)20(27)30-16-7-11-6-13(3-4-17(24)25)29-9-14(11)19(26)21(16,2)28/h3-6,8,16,22-23,28H,7,9H2,1-2H3,(H,24,25)/b4-3+/t16-,21-/m0/s1
|
|
InChIKey |
JIHUSDLTKANHNQ-HXOPIXBZSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | 139589650 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 416.4 | ALogp: | 1.6 |
HBD: | 4 | HBA: | 9 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 151.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.427 |
Caco-2 Permeability: | -5.609 | MDCK Permeability: | 0.00001670 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.979 |
Human Intestinal Absorption (HIA): | 0.319 | 20% Bioavailability (F20%): | 0.993 |
30% Bioavailability (F30%): | 0.993 |
Blood-Brain-Barrier Penetration (BBB): | 0.194 | Plasma Protein Binding (PPB): | 84.74% |
Volume Distribution (VD): | 0.279 | Fu: | 6.54% |
CYP1A2-inhibitor: | 0.404 | CYP1A2-substrate: | 0.108 |
CYP2C19-inhibitor: | 0.059 | CYP2C19-substrate: | 0.044 |
CYP2C9-inhibitor: | 0.411 | CYP2C9-substrate: | 0.878 |
CYP2D6-inhibitor: | 0.438 | CYP2D6-substrate: | 0.112 |
CYP3A4-inhibitor: | 0.593 | CYP3A4-substrate: | 0.128 |
Clearance (CL): | 6.254 | Half-life (T1/2): | 0.861 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.881 |
Drug-inuced Liver Injury (DILI): | 0.956 | AMES Toxicity: | 0.156 |
Rat Oral Acute Toxicity: | 0.234 | Maximum Recommended Daily Dose: | 0.963 |
Skin Sensitization: | 0.813 | Carcinogencity: | 0.864 |
Eye Corrosion: | 0.061 | Eye Irritation: | 0.866 |
Respiratory Toxicity: | 0.817 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002726 | ![]() |
0.826 | D07MGA | ![]() |
0.268 | ||
ENC002211 | ![]() |
0.818 | D0V9EN | ![]() |
0.261 | ||
ENC002132 | ![]() |
0.787 | D08NQZ | ![]() |
0.250 | ||
ENC003304 | ![]() |
0.780 | D0KN2M | ![]() |
0.247 | ||
ENC003640 | ![]() |
0.636 | D0J2NK | ![]() |
0.237 | ||
ENC002131 | ![]() |
0.633 | D0R6RC | ![]() |
0.237 | ||
ENC003449 | ![]() |
0.577 | D08LTU | ![]() |
0.235 | ||
ENC003838 | ![]() |
0.577 | D04AIT | ![]() |
0.230 | ||
ENC003839 | ![]() |
0.577 | D0Y5RZ | ![]() |
0.229 | ||
ENC005503 | ![]() |
0.570 | D02GAC | ![]() |
0.227 |